This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohkuma, H. Articles by Sobata, E. Search for Related Content PubMed PubMed Citation Articles by Ohkuma, H. Articles by Sobata, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Transient Ischemic Attack

Stroke, Vol 22, 854-859, Copyright © 1991 by American Heart Association

ARTICLES

Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage

H Ohkuma, S Suzuki, M Kimura and E Sobata
Department of Neurosurgery, Hirosaki University School of Medicine, Japan.

To evaluate the role of platelet function in the pathogenesis of cerebral vasospasm, we compared sequential changes of platelet aggregability and beta-thromboglobulin and thromboxane B2 concentrations in blood samples from the internal jugular and peripheral vein of 13 patients with aneurysmal subarachnoid hemorrhage. Platelet function in blood from the internal jugular vein tended to be enhanced during days 0-1 but recovered to the normal range during days 2-4. After day 5, platelet function showed various patterns depending on the presence of symptomatic vasospasm. In patients without symptomatic vasospasm, sequential changes were relatively minor, with normal or slightly high values. Patients with symptomatic vasospasm already showed high platelet aggregability during the early stage of vasospasm. The concentration of beta-thromboglobulin increased several days after the onset of vasospasm, reaching 80 ng/ml or more in patients with a poor prognosis. Two of the five patients with symptomatic vasospasm showed markedly high concentrations of thromboxane B2 after day 8. These results suggest that vasospasm activates platelets and promotes aggregability and that the resulting increased tendency for thrombus formation may affect the patient's prognosis during the advanced stage.

This article has been cited by other articles:

				S. M. Dorhout Mees, G. J.E. Rinkel, J. W. Hop, A. Algra, and J. van Gijn Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review Stroke, September 1, 2003; 34(9): 2285 - 2289. [Abstract] [Full Text] [PDF]

				J. van Gijn and G. J. E. Rinkel Subarachnoid haemorrhage: diagnosis, causes and management Brain, February 1, 2001; 124(2): 249 - 278. [Abstract] [Full Text] [PDF]

				J. W. Hop, G. J. E. Rinkel, A. Algra, J. W. B. van der Sprenkel, and J. van Gijn Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage Neurology, February 22, 2000; 54(4): 872 - 878. [Abstract] [Full Text] [PDF]

				J. W. Hop, G. J. E. Rinkel, A. Algra, and J. van Gijn Initial Loss of Consciousness and Risk of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage Stroke, November 1, 1999; 30(11): 2268 - 2271. [Abstract] [Full Text] [PDF]

				S. Kobayashi, K. Okada, H. Koide, H. Bokura, and S. Yamaguchi Subcortical Silent Brain Infarction as a Risk Factor for Clinical Stroke Stroke, October 1, 1997; 28(10): 1932 - 1939. [Abstract] [Full Text]